Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ALBERT, Istvan")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

Conserved network motifs allow protein-protein interaction predictionALBERT, Istvan; ALBERT, Réka.Bioinformatics (Oxford. Print). 2004, Vol 20, Num 18, pp 3346-3352, issn 1367-4803, 7 p.Article

GeneTrack-a genomic data processing and visualization frameworkALBERT, Istvan; WACHI, Shinichiro; CIZHONG JIANG et al.Bioinformatics (Oxford. Print). 2008, Vol 24, Num 10, pp 1305-1306, issn 1367-4803, 2 p.Article

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III TrialSCAGLIOTTI, Giorgio V; KRZAKOWSKI, Maciej; PAPAI, Zsolt S et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, issn 0732-183X, 9 p.Article

Translational and rotational settings of H2A.Z nucleosomes across the Saccharomyces cerevisiae genomeALBERT, Istvan; MAVRICH, Travis N; TOMSHO, Lynn P et al.Nature (London). 2007, Vol 446, Num 7135, pp 572-576, issn 0028-0836, 5 p.Article

White Button Mushrooms Increase Microbial Diversity and Accelerate the Resolution of Citrobacter rodentium Infection in MiceVARSHNEY, Jyotika; HUI OOI, Jot; JAYARAO, Bhushan M et al.The Journal of nutrition. 2013, Vol 143, Num 4, pp 526-532, issn 0022-3166, 7 p.Article

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non―Small-Cell Lung CancerLARA, Primo N; DOUILLARD, Jean-Yves; FANDI, Abderrahim et al.Journal of clinical oncology. 2011, Vol 29, Num 22, pp 2965-2971, issn 0732-183X, 7 p.Article

Phase 2 Trial Results With the Novel Neurokinin-1 Receptor Antagonist Casopitant in Combination With Ondansetron and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients Receiving Moderately Emetogenic ChemotherapyARPORNWIRAT, Wichit; ALBERT, Istvan; HANSEN, Vincent L et al.Cancer. 2009, Vol 115, Num 24, pp 5807-5816, issn 0008-543X, 10 p.Article

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancerLANGER, Corey J; ALBERT, Istvan; SCHREEDER, Marshall T et al.Lung cancer. 2014, Vol 85, Num 3, pp 420-428, issn 0169-5002, 9 p.Article

Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non-Small-Cell Lung CancerSCAGLIOTTI, Giorgio; NOVELLO, Silvia; AREN, Osvaldo et al.Journal of clinical oncology. 2010, Vol 28, Num 11, pp 1835-1842, issn 0732-183X, 8 p.Article

Nucleosome organization in the Drosophila genomeMAVRICH, Travis N; CIZHONG JIANG; GILMOUR, David S et al.Nature (London). 2008, Vol 453, Num 7193, pp 358-362, issn 0028-0836, 5 p.Article

Nucleosome positions predicted through comparative genomicsIOSHIKHES, Ilya P; ALBERT, Istvan; ZANTON, Sara J et al.Nature genetics. 2006, Vol 38, Num 10, pp 1210-1215, issn 1061-4036, 6 p.Article

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung CancerSORIA, Jean-Charles; MARK, Zsuzsanna; HEI, Yong-Jiang et al.Journal of clinical oncology. 2011, Vol 29, Num 33, pp 4442-4451, issn 0732-183X, 10 p.Article

  • Page / 1